SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma - Quaterly Results

20 Jul 2022 Evaluate
Net sales declined -25.74%  to  Rs. 8568.98 million from Rs. 11539.00 millions.The Company to register a -34.57%  fall in the net profit for the quarter ended June 2022.The Operating Profit of the company witnessed a decrease to 3445.95 millions from 4981.41 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 8568.98 11539.00 -25.74 8568.98 11539.00 -25.74 44007.08 34628.76 27.08
Other Income 743.92 618.40 20.30 743.92 618.40 20.30 2239.40 1347.76 66.16
PBIDT 3445.95 4981.41 -30.82 3445.95 4981.41 -30.82 17345.79 14370.43 20.70
Interest 9.00 10.01 -10.09 9.00 10.01 -10.09 52.40 34.11 53.62
PBDT 3436.95 4971.40 -30.87 3436.95 4971.40 -30.87 17293.39 14336.32 20.63
Depreciation 349.11 252.77 38.11 349.11 252.77 38.11 1102.96 987.80 11.66
PBT 3087.84 4718.63 -34.56 3087.84 4718.63 -34.56 16190.43 13348.52 21.29
TAX 793.30 1211.88 -34.54 793.30 1211.88 -34.54 4068.88 3378.47 20.44
Deferred Tax 38.90 -15.06 -358.30 38.90 -15.06 -358.30 140.08 1.20 11573.33
PAT 2294.54 3506.75 -34.57 2294.54 3506.75 -34.57 12121.55 9970.05 21.58
Equity 164.65 163.90 0.46 164.65 163.90 0.46 164.30 163.59 0.43
PBIDTM(%) 40.21 43.17 -6.85 40.21 43.17 -6.85 39.42 41.50 -5.02

Gland Pharma Share Price

1795.80 59.80 (3.44%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×